A Columbia University-led multicenter research effort called IndiPHARM: individual metabolome and exposome assessment for pharmaceutical optimization will develop a platform and monitoring system to prevent unwanted interactions between medications and other environmental, genetic, and lifestyle factors, in order to optimize therapeutic efficacy.
Compounded semaglutide is an ill-defined public health crisis
I first met Jane (not her real name, of course) on a Friday afternoon in our clinic. She was referred for further evaluation of her
September 13, 2024